Drinking more water did not slow kidney decline in the one trial that tested it
Observational studies link higher water intake to healthier kidneys. When a randomised trial coached people with kidney disease to drink more, their filtration fell at the same rate as the control group.
| Group | Value (mL/min/1.73m²) |
|---|---|
| Drink-more-water group | 2.2 |
| Usual-intake group | 1.9 |
The idea that drinking more water protects the kidneys is intuitive and widely repeated, but the one randomised trial designed to test it found no benefit: among adults with chronic kidney disease, coaching people to drink more water did not slow the decline in kidney function over a year compared with coaching them to keep their usual intake [s1]. The observational link between higher water intake and healthier kidneys is real in the data — it just did not hold up when put to a controlled test [s1] [s2].
Where the belief comes from
The belief has an evidence base, and it is worth stating fairly. A cross-sectional analysis of US National Health and Nutrition Examination Survey data examined the relationship between total water intake, chronic kidney disease and cardiovascular disease in the general population [s2]. Among 3,427 adults, 13% had chronic kidney disease [s2]. Those with the lowest total water intake, under 2.0 litres a day, had higher odds of chronic kidney disease than those with the highest intake, over 4.3 litres a day — an adjusted odds ratio of 2.52, though with a wide confidence interval that crossed 1 (95% CI, 0.91 to 6.96) [s2]. This is the kind of finding that launches a health rule: a plausible mechanism, animal support, and a population association pointing the expected way.
But an association like this cannot separate cause from consequence or from confounding. People who drink less water may differ in many ways from people who drink more, and impaired kidneys may change thirst and fluid handling rather than the other way round. That is what a randomised trial is for.
What the trial actually did
The CKD WIT trial — Chronic Kidney Disease Water Intake Trial — ran at nine centres in Ontario, Canada, from 2013 to 2017 [s1]. It enrolled 631 patients with stage 3 chronic kidney disease, randomising 316 to a hydration group coached to drink more water and 315 to a control group coached to maintain their usual intake [s1]. The coaching worked as intended: the hydration group's 24-hour urine volume rose by 0.6 litres a day more than the control group's, a clear, statistically significant separation confirming the two groups really did drink differently [s1].
The kidneys did not care. The primary outcome was the change in estimated glomerular filtration rate — eGFR, the standard measure of filtering capacity — over 12 months. It fell by 2.2 mL/min/1.73m² in the hydration group and by 1.9 in the control group, an adjusted between-group difference of just −0.3 (95% CI, −1.8 to 1.2; P = .74) [s1]. That is a null result: the extra water made no meaningful difference to how fast kidney function declined [s1]. A marker of the body's water-conserving hormone, plasma copeptin, did fall more in the hydration group, confirming the intervention reached the physiology it was aimed at — but the filtration outcome that matters did not move [s1].
The honest caveat the authors themselves raise
The trial's own conclusion carries a limit worth quoting in spirit: the authors note the study may have been underpowered to detect a clinically important difference [s1]. A single one-year trial in stage 3 disease cannot rule out a small benefit, or a benefit over a longer horizon, or a benefit in a different group — such as people prone to kidney stones, for whom higher fluid intake has separate and better evidence, or people who are genuinely dehydrated. What CKD WIT does establish is narrower and still useful: coaching people with established kidney disease to drink substantially more water, enough to raise urine output by more than half a litre a day, did not slow their decline over a year [s1].
What this leaves a reader with
Higher water intake tracks with better kidney health in observational data, but the trial built to test whether drinking more causes better kidney function found no effect on the decline of filtration over a year [s1] [s2]. That does not argue for drinking too little — ordinary thirst-guided intake and the separate, stronger case for fluids in kidney-stone prevention both stand. It argues against the specific claim that pushing extra water protects failing kidneys, which the one randomised test did not support. Anyone with chronic kidney disease has fluid targets that are genuinely individual, and a matter for their clinician rather than a general rule.
This article is informational and is not medical advice.
Sources
- Effect of Coaching to Increase Water Intake on Kidney Function Decline in Adults With Chronic Kidney Disease: The CKD WIT Randomized Clinical Trial — JAMA, 2018-05-08
- Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES data — American Journal of Nephrology, 2013-04-17
Sources
- Effect of Coaching to Increase Water Intake on Kidney Function Decline in Adults With Chronic Kidney Disease: The CKD WIT Randomized Clinical Trial — JAMA , May 8, 2018
- Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES data — American Journal of Nephrology , April 17, 2013
More on
Protecting your kidneys is mostly about two conditions you cannot feel
Kidney disease is usually silent until it is advanced, and most of it traces to diabetes and high blood pressure. Controlling those two, and getting tested, is the highest-yield protection — not kidney superfoods.
SGLT2 drugs slow kidney disease and cut heart events — with or without diabetes
A meta-analysis of 90,000 people found these diabetes-origin drugs reduced kidney disease progression by 37% and cardiovascular events by 23%, and the benefit was similar in people who did not have diabetes.
Lowering high uric acid did not protect the kidneys in two randomised trials
High urate levels track with worsening kidney disease, so treating them seemed a logical way to slow it. Two trials that lowered urate with allopurinol found the kidneys declined at the same rate anyway.
In kidney disease, cutting salt lowers blood pressure and protein leak into urine
In people who already have kidney disease, cutting salt reduced albuminuria by about 36% and lowered blood pressure. High salt also blunts standard kidney-protecting drugs — though long-term outcome trials are missing.